Neuphoria Therapeutics Inc. Income From Continuing Operations Attributable To Owners Of Parent
Neuphoria Therapeutics Inc. (NEUP) reported Income From Continuing Operations Attributable To Owners Of Parent of AUD 913.37 thousand for the 12-month period ending 2022-06-30, per its 20-F filed 2022-10-14.
Discontinued › Income Statement › Other Income
ifrs-full:IncomeFromContinuingOperationsAttributableToOwnersOfParent · last filed 2022-10-14
| Period end | Income From Continuing Operations Attributable To Owners Of Parent 12 month |
|---|---|
| 2022-06-30 | 913.37K AUD 20-F · filed 2022-10-14 |
| 2021-06-30 | 892.51K AUD 20-F · filed 2022-10-14 |
| 2020-06-30 | 1.33M AUD 20-F · filed 2022-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |